Barbara Borroni
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Docosahexaenoic Acid (DHA) Replacement for Treatment in Spinocerebellar Ataxia 38 (NCT03109626) | Barbara Borroni | 2015-06-17 |
Track Barbara Borroni automatically
Every clearance here is in the API, with alerts when new ones post.